Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Eloranta

Showing results (21-30 of 117) with videos related to

Pageof 12
Sort By:
European Journal of Haematology|September 2, 2020
Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemiaFredrik Baecklund, Sara Ekberg, Richard Rosenquist, et al.
BMC Cancer|November 6, 2015
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based studyMohammad Mohammadi, Yang Cao, Ingrid Glimelius, et al.
European Urology|June 8, 2013
Reply to Silvia Selinski, Daniel Ovsiannikov, Jan G. Hengstler and Klaus Golka's Letter to the editor re: Caroline E. Weibull, Sandra Eloranta, Daniel Altman, Anna L.V. Johansson, Mats Lambe. Childbearing and the risk of bladder cancer: a nationwide population-based cohort study. Eur Urol 2013;63:733-8Caroline E Weibull, Sandra Eloranta, Anna L V Johansson, et al.
International Journal of Cancer|June 22, 2017
Primary tumor sites in relation to ultraviolet radiation exposure and skin visibility correlate with survival in cutaneous melanomaDaniela Gordon, Johan Hansson, Sandra Eloranta, et al.
Epidemiology (Cambridge, Mass.)|July 19, 2014
The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survivalSandra Eloranta, Paul C Lambert, Therese M-L Andersson, et al.
Breast Cancer Research and Treatment|November 4, 2017
Safety of fertility preservation in breast cancer patients in a register-based matched cohort studyKenny A Rodriguez-Wallberg, Sandra Eloranta, Kamilla Krawiec, et al.
British Journal of Haematology|July 31, 2021
Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab eraElsa Brånvall, Sara Ekberg, Sandra Eloranta, et al.
American Journal of Hematology|December 23, 2016
Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapyIngrid Glimelius, Sandra Eloranta, Sara Ekberg, et al.
Statistics in Medicine|September 17, 2013
Estimating the loss in expectation of life due to cancer using flexible parametric survival modelsTherese M-L Andersson, Paul W Dickman, Sandra Eloranta, et al.
Peerj|October 18, 2024
Predicting maintenance lithium response for bipolar disorder from electronic health records-a retrospective studyJoseph F Hayes, Fehmi Ben Abdesslem, Sandra Eloranta, et al.
Pageof 12

Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
European Journal of Haematology|September 2, 2020
Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemiaFredrik Baecklund, Sara Ekberg, Richard Rosenquist, et al.
BMC Cancer|November 6, 2015
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based studyMohammad Mohammadi, Yang Cao, Ingrid Glimelius, et al.
European Urology|June 8, 2013
Reply to Silvia Selinski, Daniel Ovsiannikov, Jan G. Hengstler and Klaus Golka's Letter to the editor re: Caroline E. Weibull, Sandra Eloranta, Daniel Altman, Anna L.V. Johansson, Mats Lambe. Childbearing and the risk of bladder cancer: a nationwide population-based cohort study. Eur Urol 2013;63:733-8Caroline E Weibull, Sandra Eloranta, Anna L V Johansson, et al.
International Journal of Cancer|June 22, 2017
Primary tumor sites in relation to ultraviolet radiation exposure and skin visibility correlate with survival in cutaneous melanomaDaniela Gordon, Johan Hansson, Sandra Eloranta, et al.
Epidemiology (Cambridge, Mass.)|July 19, 2014
The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survivalSandra Eloranta, Paul C Lambert, Therese M-L Andersson, et al.
Breast Cancer Research and Treatment|November 4, 2017
Safety of fertility preservation in breast cancer patients in a register-based matched cohort studyKenny A Rodriguez-Wallberg, Sandra Eloranta, Kamilla Krawiec, et al.
British Journal of Haematology|July 31, 2021
Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab eraElsa Brånvall, Sara Ekberg, Sandra Eloranta, et al.
American Journal of Hematology|December 23, 2016
Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapyIngrid Glimelius, Sandra Eloranta, Sara Ekberg, et al.
Statistics in Medicine|September 17, 2013
Estimating the loss in expectation of life due to cancer using flexible parametric survival modelsTherese M-L Andersson, Paul W Dickman, Sandra Eloranta, et al.
Peerj|October 18, 2024
Predicting maintenance lithium response for bipolar disorder from electronic health records-a retrospective studyJoseph F Hayes, Fehmi Ben Abdesslem, Sandra Eloranta, et al.
Pageof 12